Released during platelet aggregation. Neutralizes the anticoagulant effect of heparin because it binds more strongly to heparin than to the chondroitin-4-sulfate chains of the carrier molecule. Chemotactic for neutrophils and monocytes. Inhibits endothelial cell proliferation, the short form is a more potent inhibitor than the longer form.

推荐稀释比 WB:1/500-1/1000;IHC:1/50-1/100;IP:1/50

Western blot analysis of PF4 in Human spleen lysates using PF4 antibody.

-25 ~ -15℃保存，收到货之后有效期1年，避免反复冻融。